Azione A185750 CHONG KUN DANG PHARMACEUTICAL CORP.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Chong Kun Dang Pharmaceutical Corp.

Azioni

A185750

KR7185750007

Prezzo di chiusura Korea S.E.
Altri mercati azionari
 00:00:00 10/05/2024 		Variaz. 5gg Var. 1 gen.
103.200 KRW +0,58% Grafico intraday di Chong Kun Dang Pharmaceutical Corp. -0,29% -21,16%
23/01 Chong Kun Dang Pharmaceutical Corp. (KOSE:A185750) annuncia un riacquisto di azioni per un valore di 15.000 milioni di KRW. CI
23/01 Chong Kun Dang Pharmaceutical Corp. autorizza un piano di riacquisto. CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on January 23, 2024.
Chong Kun Dang Pharmaceutical Corp. announces an Equity Buyback for KRW 15,000 million worth of its shares.
Chong Kun Dang Pharmaceutical Corp. authorizes a Buyback Plan.
Chong Kun Dang Pharmaceutical Inks Largest-Ever Technology Transfer Agreement with Novartis
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 13, 2022.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 13, 2022.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 13, 2022.
Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback announced on October 13, 2022, has expired with 62,127 shares, representing 0.51% for KRW 4,856.39 million.
Chong Kun Dang Pharmaceutical Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.
Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback announced on February 10, 2022, has expired with 109,064 shares, representing 0.89% for KRW 9,895.01 million.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 13, 2022.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione A185750
  4. Notizie Chong Kun Dang Pharmaceutical Corp.
  5. Altre lingue